A randomized control trial between fosfomycin and cefuroxime as the antibiotic prophylaxis in knee arthroplasty.

BACKGROUND Antibiotic prophylaxis is used in all patient underwent total knee arthroplasty to prevent post operative infection which produced poor outcome. The suitable drug should be safe and good efficacy. OBJECTIVE To study safety and efficacy of fosfomicin and cefuroxime as antibiotic prophylaxis for total knee arthroplasty. MATERIAL AND METHOD The control trial was performed to find out efficacy and safety of fosfomycin as an antibiotic prophylaxis comparing to cefuroxime. There were 112 patients, 14 male and 98 female, with their ages ranged between 57 and 86 years. They were randomly divided into two groups, the fosfomycin group, 56 patients and the cefuroxime group, 56 patients. All patients underwent elective knee arthroplasty by the authors. The scheduled antibiotics were given perioperatively for 24 hours and all patients were followed-up for 6 months. Physical examination, skin temperature of the operated knee, radiograph and blood tests were carried out in the patients to monitor post operative infection, renal and liver disturbance. RESULTS One patient in the cefuroxime group had local wound infection which responded well to local treatment and administration of antibiotics. No patients had post operative infection at the 6 months follow-up. No patients had any complication and none had renal and liver function disturbance during the follow-up. CONCLUSION Comparing to cefuroxime,fosfomycin is safe and effective for the use as antibiotic prophylaxis in knee arthroplasty.

[1]  P. Choong,et al.  Microbiological Aetiology, Epidemiology, and Clinical Profile of Prosthetic Joint Infections: Are Current Antibiotic Prophylaxis Guidelines Effective? , 2012, Antimicrobial Agents and Chemotherapy.

[2]  M. Falagas,et al.  Fosfomycin: evaluation of the published evidence on the emergence of antimicrobial resistance in Gram-negative pathogens. , 2012, The Journal of antimicrobial chemotherapy.

[3]  Gwo-Chin Lee,et al.  Does Dual Antibiotic Prophylaxis Better Prevent Surgical Site Infections in Total Joint Arthroplasty? , 2012, Clinical orthopaedics and related research.

[4]  A. Michalopoulos,et al.  The revival of fosfomycin. , 2011, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[5]  L. Lidgren,et al.  Timing of preoperative antibiotics for knee arthroplasties: Improving the routines in Sweden , 2011, Patient safety in surgery.

[6]  K. Kaye,et al.  Revisiting “Older” Antimicrobials in the Era of Multidrug Resistance , 2011, Pharmacotherapy.

[7]  E. Lambiris,et al.  Antibiotic prophylaxis in primary hip and knee arthroplasty: comparison between cefuroxime and two specific antistaphylococcal agents. , 2010, The Journal of arthroplasty.

[8]  A. Lombardi,et al.  Minimizing Infection Risk: Fortune Favors the Prepared Mind , 2010 .

[9]  L. Lidgren,et al.  Inadequate timing of prophylactic antibiotics in orthopedic surgery. We can do better , 2009, Acta orthopaedica.

[10]  Hien H. Nguyen,et al.  Prophylactic antibiotics in hip and knee arthroplasty. , 2009, The Journal of bone and joint surgery. American volume.

[11]  A. Hutchinson,et al.  Antibiotic prophylaxis for wound infections in total joint arthroplasty: a systematic review. , 2008, The Journal of bone and joint surgery. British volume.

[12]  K. Fung,et al.  Infection in primary total knee replacement. , 2008, Hong Kong medical journal = Xianggang yi xue za zhi.

[13]  A. Rosenstein,et al.  Infection prevention in total knee and total hip arthroplasties. , 2008, American journal of orthopedics.

[14]  Gwo-Chin Lee,et al.  Case report: cefazolin-induced hemolytic anemia. , 2007, Clinical orthopaedics and related research.

[15]  A. Apisarnthanarak,et al.  Successful treatment of disseminated methicillin-resistant Staphylococcus aureus with fosfomycin, cefoperazone/sulbactam and rifampin followed by fusidic acid and rifampin. , 2007, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[16]  Ken‐ichiro Yoshida,et al.  Randomized prospective comparison of fosfomycin and cefotiam for prevention of postoperative infection following urological surgery , 2007, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[17]  T. Pieber,et al.  Second-line Treatment of Limb-Threatening Diabetic Foot Infections with Intravenous Fosfomycin , 2005, Journal of chemotherapy.

[18]  R. Spencer,et al.  C reactive protein and skin temperature post total knee replacement. , 2005, The Knee.

[19]  D. Fry,et al.  Use of antimicrobial prophylaxis for major surgery: baseline results from the National Surgical Infection Prevention Project. , 2005, Archives of surgery.

[20]  R. Rahmanzadeh,et al.  Adjuvant fosfomycin medication in chronic osteomyelitis , 1989, Infection.

[21]  K. Oungbho,et al.  The efficacy of a hydroxyapatite composite as a biodegradable antibiotic delivery system. , 2004, Clinical orthopaedics and related research.

[22]  G. Bannister,et al.  Infection after total knee arthroplasty. , 2004, The Journal of bone and joint surgery. British volume.

[23]  A. Hanssen Prophylactic use of antibiotic bone cement: an emerging standard--in opposition. , 2004, The Journal of arthroplasty.

[24]  S. Hughes,et al.  Cefuroxime in CMW bone cement , 1985, International Orthopaedics.

[25]  D. Nadal,et al.  Fosfomycin for the initial treatment of acute haematogenous osteomyelitis , 2003, Archives of disease in childhood.

[26]  O. Bajolet,et al.  Postoperative Spondylodiskitis due to Stomatococcus mucilaginosus in an Immunocompetent Patient , 2003, Scandinavian journal of infectious diseases.

[27]  W. Lo,et al.  Cefuroxime-Impregnated Cement in Primary Total Knee Arthroplasty: A Prospective, Randomized Study of Three Hundred and Forty Knees , 2002, The Journal of bone and joint surgery. American volume.

[28]  R. Viola,et al.  Postoperative Infections Following Total Knee Replacement: An Epidemiological Study , 2001, Journal of chemotherapy.

[29]  F. Lalla Antibiotic prophylaxis in orthopedic prosthetic surgery. , 2001 .

[30]  A. Baldini,et al.  [Risk factors and prevention of infections of hip and knee prostheses]. , 2000, Journal of chemotherapy.

[31]  B. Allaouchiche,et al.  [Diffusion in bone tissue of antibiotics]. , 1999, Presse medicale.

[32]  K. Lewis Audit of timing of antibiotic prophylaxis in hip and knee arthroplasty. , 1998, Journal of the Royal College of Surgeons of Edinburgh.

[33]  G. Maclellan,et al.  Postoperative changes of erythrocyte sedimentation rate, plasma viscosity and C-reactive protein levels after hip surgery. , 1998, Acta orthopaedica Belgica.

[34]  S. Stern,et al.  Diagnosis and management of the infected total knee arthroplasty. , 1996, The American journal of knee surgery.

[35]  V. Hernández Casado Fosfomycin in a traumatological department. , 1977, Chemotherapy.